DF, M., C, M., B, K., M, B., A, R., & PB, J. (2026). Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. https://doi.org/10.1002/ncp.70109
Chicago Style (17th ed.) CitationDF, Mercer, Mubekapi-Musadaidzwa C, Kloster B, Berner-Hansen M, Rydén A, and Jeppesen PB. "Exploring the Disease Burden and Quality of Life in Patients with Short Bowel Syndrome with Intestinal Failure: Insights from Exit Interviews in the Glepaglutide EASE SBS-1 Phase 3 Trial." Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition 2026. https://doi.org/10.1002/ncp.70109.
MLA (9th ed.) CitationDF, Mercer, et al. "Exploring the Disease Burden and Quality of Life in Patients with Short Bowel Syndrome with Intestinal Failure: Insights from Exit Interviews in the Glepaglutide EASE SBS-1 Phase 3 Trial." Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition, 2026, https://doi.org/10.1002/ncp.70109.